Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 23, 2015

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
Stem Cell TransplantationHaplo-identical
Interventions
OTHER

Assessment of the Allogenomic Mismatch Score (AMS)

Allogenomic Mismatch Score (AMS) is a continuous variable based on the number of nsSNP between the donor and the recipient. Roughly, the exome of the donor is aligned to the exome of the recipient, allowing to count the number of variations that will generate a peptide present in the recipient but absent in the donor.

OTHER

Assessment of the optimised Allogenomic Mismatch Score (AMS)

Optimised Allogenomic Mismatch Score (AMS) is a continuous variable based on the number of nsSNP between the donor and the recipient, encountering only peptides that can be presented by the donors' MHC (using another layer of algorithm, NetMHCpan).

Trial Locations (1)

54500

Alice Aarnink, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05243498 - Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter